Fractional CSO/CMO

Our client is a stealth startup committed to bringing the next generation of pharmaceutical treatments to combat cancer. Job Title: Fractional Chief Scientific Officer / Chief Medical Officer (Hybrid Role)Location:Remote / HybridTime Commitment: Part-time / FractionalAbout the Opportunity:• We are partnering with a stealth-mode, preclinical-stage biotechnology company advancing a first-in-class, small-molecule oncology therapeutic platform derived from a proprietary natural-compound chemical library.• With compelling in-vivo tumor eradication data and broad anti-tumor activity across multiple cancer models, the company is poised to move its lead candidate toward IND and first-in-human (FIH) studies. • They are seeking a fractional CSO/CMO hybrid who can provide strategic and hands-on leadership across preclinical development, translational planning, IND readiness, and early clinical design. Key Responsibilities:• Lead the scientific and medical strategy from late-stage preclinical through IND-enabling studies and into FIH trial planning.• Guide mechanism-of-action studies, pharmacology, toxicology, and dose rationale in collaboration with discovery and translational teams. • Oversee CROs responsible for IND-enabling studies and ensure alignment with regulatory and clinical objectives. • Contribute to bolthires product profile, clinical development plan, and biomarker strategy. • Work closely with company leadership on pipeline prioritization, scientific positioning, and external communications (including investors and potential partners).• Support preparation of regulatory documents and attend meetings with external stakeholders, as needed.? RemoteAbout the Company:Compass Consulting Apply tot his job